High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$217K
$217,684
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VIR
S
Vir Biotechnology, Inc.
de Verneuil Vanina
• Officer • EVP, General Counsel, Corp Sec
10b5-1 SellΔOwn -10.8%
2026-02-25
$134,534
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • EVP, General Counsel, Corp Sec
10b5-1 SellΔOwn -10.8%
|
2026-02-25 | $134,534 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
de Verneuil Vanina
• Officer • EVP, General Counsel, Corp Sec
Sell to Cover
2026-02-24
$29,713
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • EVP, General Counsel, Corp Sec
Sell to Cover
|
2026-02-24 | $29,713 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
de Verneuil Vanina
• Officer • EVP, General Counsel, Corp Sec
Sell to Cover
2026-02-23
$33,128
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • EVP, General Counsel, Corp Sec
Sell to Cover
|
2026-02-23 | $33,128 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
de Verneuil Vanina
• Officer • EVP, General Counsel, Corp Sec
10b5-1 Sell
2025-11-05
$12,307
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • EVP, General Counsel, Corp Sec
10b5-1 Sell
|
2025-11-05 | $12,307 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
de Verneuil Vanina
• Officer • EVP and General Counsel
Sell to Cover
2025-11-03
$8,003
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • EVP and General Counsel
Sell to Cover
|
2025-11-03 | $8,003 | S | Form 4 |